Prenatal Genetic Testing

Prenatal Genetic Testing

New research expected this year will bring about significant changes to clinical practice. Here, society leaders share what’s on their radar for 2014.

What research from the past year will have the most significant impact on women's health care? The leaders of five major ob/gyn societies weigh in.

New research presented at The Pregnancy Meeting™ last week in New Orleans shows that noninvasive prenatal testing can detect more than 80% of chromosomal abnormalities.

The ethical issues between two new technologies are stark. One aims to cure disease, whereas the other threatens to alter fundamentally the parent-child relationship.

A noninvasive test that analyzes fetal cell-free (cf) DNA in a pregnant woman’s blood can accurately detect trisomy 21 and other genetic fetal abnormalities in the first trimester, according to the results of a new study.

Diana Bianchi discusses noninvasive prenatal testing, including false positives and testing average-risk women, at ACOG's Annual Meeting.

There is limited evidence that for transcervical chorionic villus sampling (CVS), the use of small forceps may be more effective and less painful than the use of an aspiration cannula.


Subscribe to
Please Wait 20 seconds or click here to close